Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_2
2
50%
Ph phase_1
2
50%

Phase Distribution

2

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Recruiting2
Completed1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (50.0%)
Phase 22 (50.0%)

Trials by Status

completed125%
withdrawn125%
recruiting250%

Recent Activity

2 active trials
Showing 4 of 4
recruitingphase_2

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

NCT07221513
recruitingphase_2

Study of JK07 in Patients With Chronic Heart Failure

NCT06369298
completedphase_1

Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)

NCT04210375
withdrawnphase_1

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

NCT05322616

Clinical Trials (4)

Showing 4 of 4 trials
NCT07221513Phase 2

Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension

Recruiting
NCT06369298Phase 2

Study of JK07 in Patients With Chronic Heart Failure

Recruiting
NCT04210375Phase 1

Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)

Completed
NCT05322616Phase 1

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4